CORE--PEPTIDE BIOCHEMISTRY
CORE--PEPTIDE BIOCHEMISTRY
批准号:
6651774
负责人:
Bingcheng Wang
金额:
$13.53万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-01 至 2003-08-31
中文摘要
多肽生物化学核心(核心B)有两个主要目标:1)产生
并维护主要的噬菌体展示文库,作为建议的
研究,2)设计和执行实验以分离和表征
针对靶蛋白的功能阻断多肽
调查。不同的策略将应用于每个特定的
申请。对于已经克隆的蛋白质,重组
蛋白质将被提纯并固定在固体载体上。这些措施包括
与人免疫球蛋白融合的ephin-A1(前B61)(项目1);
从生产细胞系中纯化的免疫亲和性Fas配体
(项目2),和EGF残基K652-A674与GST融合(项目5)。主要
将多肽噬菌体展示文库选上重组
蛋白质。选定的噬菌体将被放大并在目标上进行选择
又是蛋白质。在这种重复的、来自于
能够与靶蛋白特异结合的噬菌体将与
商品及服务税或合成。它们将被用来测试是否阻断了EphK
信号转导(项目1),或Fas-Fas配体介导的细胞凋亡(项目2)。
在项目5中,肽序列本身将被用来推断
与EGFR K652-A674相互作用的蛋白质。自功能性重组
蛋白质不适用于离子通道ROMK1(项目3),我们将
在Sf9和Cho-Lec-1上表达。通过改变昆虫和昆虫上的噬菌体选择
哺乳动物细胞过度表达通道的非特异性结合
与总的单元格平移相关联的值将最小化。多肽将是
利用通道钳制系统合成并表征了该化合物。
英文摘要
The Peptide Biochemistry Core (Core B) has two main goals: 1) to generate
and maintain primary phage display libraries as tools for the proposed
studies, 2) to design and execute experiments to isolate and characterize
function-blocking peptides against the target proteins under
investigation. Distinct strategies will be applied to each specific
application. For proteins that have already been cloned, recombinant
proteins will be purified and immobilized on solid supports. These include
ephrin-A1 (formerly B61) fused to human IgG (ephrin-A1/IgG) (Project 1),
Fas ligand that is immuno-affinity purified from a producing cell line
(Project 2), and EGF residue K652-A674 fused to GST (Project 5). Primary
peptide phage display libraries will be selected on the recombinant
proteins. Selected phage will be amplified and selected on the target
protein again. Following such repeated, peptide coding sequences from
phage capable of specifically binding to target proteins will be fused to
GST or synthesize. They will be used to test for blocking Eph kinase
signaling (Project 1), or Fas-Fas ligand mediated apoptosis (Project 2).
In project 5, the peptide sequences themselves will be used to deduce
proteins that interact with EGFR K652-A674. Since functional recombinant
proteins are not available for ion channel ROMK1 (Project 3), we will
express it on Sf9 and CHO-Lec-1. By altering phage selection on insect and
mammalian cells overexpressing the channel the non-specific binding
associated with total cell panning will be minimized. Peptides will be
synthesized and characterized using the channel clamping systems.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting EphA2 in Glioblastoma
-
批准号:9128090
-
项目类别:
-
资助金额:$55.29万
-
财政年份:2016
-
负责人:Bingcheng Wang
-
依托单位:
Targeting EphA2 in Glioblastoma
-
批准号:9878146
-
项目类别:
-
资助金额:$50.9万
-
财政年份:2016
-
负责人:Bingcheng Wang
-
依托单位:
EphA2 kinase in prostate cancer
-
批准号:8706079
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2011
-
负责人:Bingcheng Wang
-
依托单位:
EphA2 kinase in prostate cancer
-
批准号:8544181
-
项目类别:
-
资助金额:$30.62万
-
财政年份:2011
-
负责人:Bingcheng Wang
-
依托单位:
EphA2 kinase in prostate cancer
-
批准号:8034022
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2011
-
负责人:Bingcheng Wang
-
依托单位:
EphA2 kinase in prostate cancer
-
批准号:8323855
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2011
-
负责人:Bingcheng Wang
-
依托单位:
Eph Kinase Signaling In Renal Epithelial Cells
-
批准号:7903725
-
项目类别:
-
资助金额:$4.71万
-
财政年份:2009
-
负责人:Bingcheng Wang
-
依托单位:
Eph Kinase Signaling In Renal Epithelial Cells
-
批准号:8091272
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2008
-
负责人:Bingcheng Wang
-
依托单位:
Eph Kinase Signaling In Renal Epithelial Cells
-
批准号:7588914
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2008
-
负责人:Bingcheng Wang
-
依托单位:
EphA2 Agonists as Novel Inhibitors of Tumor Progression
-
批准号:6711809
-
项目类别:
-
资助金额:$8.26万
-
财政年份:2002
-
负责人:Bingcheng Wang
-
依托单位:
EphA2 Agonists as Novel Inhibitors of Tumor Progression
-
批准号:6623831
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2002
-
负责人:Bingcheng Wang
-
依托单位:
EphA2 Agonists as Novel Inhibitors of Tumor Progression
-
批准号:6904613
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2002
-
负责人:Bingcheng Wang
-
依托单位:
EphA2 Agonists as Novel Inhibitors of Tumor Progression
-
批准号:6470384
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2002
-
负责人:Bingcheng Wang
-
依托单位:
EphA2 Agonists as Novel Inhibitors of Tumor Progression
-
批准号:7048630
-
项目类别:
-
资助金额:$26.59万
-
财政年份:2002
-
负责人:Bingcheng Wang
-
依托单位:
EphA2 Agonists as Novel Inhibitors of Tumor Progression
-
批准号:7195815
-
项目类别:
-
资助金额:$21.22万
-
财政年份:2002
-
负责人:Bingcheng Wang
-
依托单位:
Eph Kinase Signaling in Prostate Cancer
-
批准号:6787214
-
项目类别:
-
资助金额:$23.86万
-
财政年份:2001
-
负责人:Bingcheng Wang
-
依托单位:
CORE--PEPTIDE BIOCHEMISTRY
-
批准号:6499596
-
项目类别:
-
资助金额:$13.53万
-
财政年份:2001
-
负责人:Bingcheng Wang
-
依托单位:
Eph Kinase Signaling in Prostate Cancer
-
批准号:6642195
-
项目类别:
-
资助金额:$23.86万
-
财政年份:2001
-
负责人:Bingcheng Wang
-
依托单位:
Eph Kinase Signaling in Prostate Cancer
-
批准号:6522952
-
项目类别:
-
资助金额:$23.86万
-
财政年份:2001
-
负责人:Bingcheng Wang
-
依托单位:
Eph Kinase Signaling in Prostate Cancer
-
批准号:6442726
-
项目类别:
-
资助金额:$23.86万
-
财政年份:2001
-
负责人:Bingcheng Wang
-
依托单位:
海外基金